TESO 15.73 Tesco Corp $TESO Hit a 52 week low of 14.92

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
TESO 15.73 Tesco Corp $TESO Hit a 52 week low of 14.92 Closing the day 11/06/14 at 15.73 +0.25 +1.61% With a day low of 14.92 and a total volume of 350,571.

TESO Recent Posts: http://investorshangout.com/Tesco-Corp-TESO-55621/

TESO Tesco Corp Recent Headline News

Weakness Seen in Tesco (TESO): Stock Tanks 14.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:31AM CST
Tesco (TESO) fell over 14% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 15% in the past one-month time frame.
BAK: 14.22 (-0.34), OILT: 44.03 (-0.63), MUSA: 59.01 (+1.52), TESO: 15.73 (+0.25)

Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BRDR: 7.04 (+0.03), ALIM: 5.10 (+0.29), ACHN: 10.26 (+0.11), FNHC: 26.10 (-4.04), ARCP: 8.64 (-0.07), CKEC: 28.07 (+0.17), JAXB: 10.61 (+0.11), PCLN: 1,097.75 (+2.41), TESO: 15.73 (+0.25)

Tesco Corporation Reports Third Quarter 2014 Results
CNW Group - Tue Nov 04, 5:32AM CST
Tesco Corporation (NASDAQ: TESO) ("TESCO" or the "Company" today reported net income of $7.5 million, or $0.18 per diluted share, for the third quarter ended September 30, 2014. Adjusted net income for the quarter was $11.1 million, or $0.27 per diluted share, which excludes the after-tax impact of foreign currency losses in Argentina, Mexico and Russia, totaling $2.7 million, or $0.07 per diluted share, and the negative tax impact of certain losses with no tax benefit in several countries, or $0.02 per diluted share. This compares to net income of $12.7 million, or $0.31 per diluted share, in the second quarter of 2014, and net income of $11.7 million, or $0.29 per diluted share, for the third quarter of 2013. Adjusted net income in the second quarter of 2014 was $11.9 million, or $0.29 per diluted share. Third quarter 2014 revenue was $141.9 million, compared to $145.1 million for the second quarter of 2014 and to $132.2 million for the third quarter of 2013, a decrease of 2% and an increase of 7%, respectively.
TESO: 15.73 (+0.25)

Real Money's Sham Gad: Buffett's Strategy to Cut His Losses on Tesco
at The Street - Tue Oct 21, 10:34AM CDT
Investors can learn from Buffett's recent misstep with Tesco.
BRK.B: 143.29 (+0.37), BRK.A: 214,800.00 (+645.00), TESO: 15.73 (+0.25)

Tesco Corporation Schedules Third Quarter 2014 Earnings Release and Conference Call for November 4
CNW Group - Mon Oct 13, 3:15PM CDT
Tesco Corporation (NASDAQ: TESO) announced today that it will release its third quarter 2014 financial results on Tuesday, November 4, 2014 before the market opens. In conjunction with the news release, Tesco has scheduled a conference call the same day at 9:00 a.m. Central Time (10:00 a.m. Eastern Time) to discuss the quarter's results.
TESO: 15.73 (+0.25)

Tesco Faces Regulator Probe as Sainsbury Prepares Review
at The Street - Wed Oct 01, 10:49AM CDT
Tesco announced it was the subject of a regulatory probe and J Sainsbury's new CEO warned investors to brace for declining full-year sales.
TESO: 15.73 (+0.25)

Tesco Corporation to Present at the Johnson Rice 2014 Energy Conference
CNW Group - Mon Sep 29, 6:00AM CDT
Tesco Corporation (NASDAQ: TESO) announced today that the Company's management will participate in the Johnson Rice 2014 Energy Conference to be held in New Orleans, September 29 - October 1, 2014.
TESO: 15.73 (+0.25)

White Eagle Partners Issues Letter to Board of Tesco Corporation
Business Wire - Tue Sep 09, 6:01PM CDT
--Calls on the Board Instead to Commit to Material Stock Buy-backs
TESO: 15.73 (+0.25)

Downgrade Alert for Tesco (TESO)
Comtex SmarTrend(R) - Thu Aug 28, 6:57AM CDT
Tesco (NASDAQ:TESO) was downgraded from Buy to Hold at Deutsche Bank today. The stock closed yesterday at $21.34 on volume of 269,000 shares, above average daily volume of 205,000. Tesco Corporation is an international oilfield service company operating worldwide. The Company designs, manufactures, sells, and operates top drive and underbalanced drilling systems, completion products, and control, electrical, and hydraulic systems.
TESO: 15.73 (+0.25)

Tesco Corporation to Present at the 2014 Barclays CEO Energy - Power Conference
CNW Group - Tue Aug 26, 6:00AM CDT
Tesco Corporation (NASDAQ: TESO) announced today that the Company's management will participate in the 2014 Barclays CEO Energy - Power Conference to be held in New York City, September 2 - 4, 2014.
TESO: 15.73 (+0.25)

Tesco Corporation Announces Succession Plans
PR Newswire - Thu Aug 21, 3:15PM CDT
Tesco Corporation (NASDAQ: TESO) today announced that Julio M. Quintana, President and Chief Executive Officer, has elected to retire at the beginning of January, 2015. In accordance with the company's succession plan, the board has designated Fernando R. Assing, currently Executive Vice-President and Chief Operating Officer, to succeed Mr. Quintana.
TESO: 15.73 (+0.25)

Tesco Corporation Announces Third Quarter Dividend
CNW Group - Fri Aug 08, 7:08AM CDT
Tesco Corporation (NASDAQ: TESO) announced today that its Board of Directors approved a third quarter dividend of $0.05 per share of common stock issued and outstanding at the close of business on August 22, 2014 (the "Record Date" . The dividend will be payable on September 2, 2014 to stockholders of record at the close of business on the Record Date.
TESO: 15.73 (+0.25)

Tesco Corporation Reports Second Quarter 2014 Results
PR Newswire - Fri Aug 01, 5:00AM CDT
Tesco Corporation (NASDAQ: TESO) ("TESCO" or the "Company" today reported net income of $12.7 million, or $0.31 per diluted share, for the second quarter ended June 30, 2014. Adjusted net income for the quarter was $11.9 million, or $0.29 per diluted share, which excludes the after-tax impact of foreign currency gains in Argentina and Venezuela, totaling $0.8 million, or $0.02 per diluted share. This compares to net income of $3.0 million, or $0.07 per diluted share, in the first quarter of 2014, and net income of $10.2 million, or $0.26 per diluted share, for the second quarter of 2013. Adjusted net income in the first quarter of 2014 was $8.4 million, or $0.21 per diluted share. Second quarter 2014 revenue was $145.1 million, compared to $121.4 million for the first quarter of 2014 and to $129.0 million for the second quarter of 2013.
TESO: 15.73 (+0.25)

Tesco Corp. (TESO) Stock Research Links

TESO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

RPA Market Set to Surge with Digital Transformation Support

Updated Category News Views 218

Understanding the Growth of the Robotic Process Automation Market The Robotic Process Automation (RPA) market is experiencing remarkable growth, with forecasts indicating an increase from USD 2.8 billion in 2023 to a staggering USD 38.4 billion by 2032. This impressive growth, at a compound annual growth rate (CAGR) of 33.8% from 2024 to 2032, reflects the growing...

Continue Reading
Unlocking Hidden Gems: Two Undervalued China Stocks to Buy

Updated Category News Views 246

Discovering Hidden Opportunities in China's Stock Market As the Chinese stock market experiences a renewed rally, discerning investors are on the lookout for undervalued companies with promising growth prospects. In a landscape dominated by major players like Alibaba and Tencent, two lesser-known stocks are gaining attention: Futu Holdings (NASDAQ: FUTU) and Atour...

Continue Reading
Exploring the Rise of Medical Spas: A Booming Industry

Updated Category News Views 186

Introduction to the Medical Spa Industry The medical spa industry is experiencing an exciting evolution, reflecting a shift in consumer preferences towards services that combine traditional spa ambiance with the expertise of medical professionals. With an increasing focus on aesthetic wellness and anti-aging solutions, we are witnessing an impressive market growth...

Continue Reading
Coherent Corp. Launches Chameleon Discovery LX Laser for Researchers

Updated Category News Views 189

Coherent Corp. Launches an Innovative Femtosecond Laser Coherent Corp. (NYSE: COHR), a renowned leader in the laser and photonics industry, has unveiled the Chameleon Discovery LX, an exciting new addition to its esteemed Chameleon Discovery product line. This revolutionary femtosecond laser is specifically designed for researchers engaged in nonlinear microscopy and...

Continue Reading
Neuronetics Shows Strong Revenue Growth Amid CEO Transition

Updated Category News Views 134

Neuronetics Reports Impressive Q3 2025 Results Neuronetics, Inc., a leader in neurohealth therapies, has shared substantial financial achievements for the third quarter of 2025. The company reported total revenues of $37.3 million, marking an significant adjusted pro forma growth of 11% compared to the same quarter in the previous year. This success can largely be...

Continue Reading